AddexPharma terminates Phase 2b/3 study of Dipraglurant in dyskinesia-associated with Parkinsons - due to the slow recruitment of patients

due to the slow recruitment of patients & staffing shortages/turnover within study sites related to #COVID19

addextherapeutics.com/en/in...

[park_bear]

Covid has wrought havoc on clinical trials.